axialHealthcare, a Nashville, Tenn.-based care optimization company navigating substance use issues for patients, providers, and health plans, closed $15m in Seris C financing.
The round was led by previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund.
The company intends to use the funds to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector.
The company also announced it has launched a new modernized brand identity that reflects the company’s expanded scope, both of which are designed to meet the needs of patients, providers, and health plans during the evolving opioid overdose epidemic.
Led by Carter Paine, CEO, axialHealthcare connects patients, providers, and health plans with a platform that covers the entire substance use spectrum. Leveraging services grounded in analytics, its risk to recovery platform identifies patients at risk, prevents escalation in their condition, and supports appropriate treatment enrollment and adherence.
When patients in need of treatment are identified, the company’s clinical team assesses individual patient needs, connects them with appropriate treatment, and provides peer recovery support specialists to guide them throughout their journey to sustained recovery.